ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 678869 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 678869; 2) Community: the network communities that were significantly associated with the response to NSC 678869; 3) Molecule: the relationships between components within communities and NSC 678869; 4) MDR: the compounds that were significantly associated with the NSC 678869.

NSC Compound Enrichment Correlation
NSC 659609 Null 0.0285477013888569 0.27577247
NSC 669229 2-trans-n-buten-1-yl-estradiol 0.0285477013888569 0.26787279
NSC 676776 Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-D-xylopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylopyranosyl)]- 0.0285477013888569 -0.010582619
NSC 699069 Null 0.0297837393005855 0.17536601
NSC 717189 Null 0.0297837393005855 0.32961275
NSC 144126 Null 0.0297837393005856 0.24077302
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0297837393005856 0.17173146
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0297837393005856 0.29906087
NSC 321491 Null 0.0297837393005856 0.16342475
NSC 328410 Camptothecin Derivative 0.0297837393005856 0.071428492
Total:77  Current:47    [First] [Prev] [Next] [Last]